Influenza vaccination in cancer patients
New PhD dissertation from DCE looks at the use of influenza vaccination among cancer patients with a focus on predictors of receiving the vaccine and clinical outcomes.
Lau Amdisen who defended his PhD dissertation today has conducted studies on predictors and clinical outcomes in relation to influenza vaccination in cancer patients.
Cancer patients with impaired immune systems are at increased risk of influenza-related hospitalisation and mortality. Therefore, they are offered the annual influenza vaccine free of charge. This vaccine is considered the most effective tool in preventing influenza infection and the following complications.
The PhD project investigated both the health-related and social factors that influence the receipt of the influenza vaccine and whether mortality is reduced for cancer patients who received the influenza vaccine. The project has utilised nationwide data from Danish registries.
The summary is written by the PhD student.